Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Vera Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 70 | +12 |
| Shares | 21.3M | 2.96M | 37.4M | +19.0M (+103.3%) |
| Value | $412.8M | $57.3M | $289.7M | −$65.7M (−18.5%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Vera Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (10)
Institutions that held Vera Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Vivo Capital, LLC | 400,666 | $7.75M |
| Logos Global Management LP | 285,000 | $5.51M |
| Swiss National Bank | 35,900 | $694.7K |
| Pura Vida Investments, LLC | 35,372 | $684.4K |
| Moore Capital Management, LP | 25,000 | $483.8K |
| Dimensional Fund Advisors LP | 11,498 | $223.0K |
| Walleye Trading LLC | 10,945 | $211.8K |
| Credit Suisse AG | 9,558 | $184.9K |
| Gyon Technologies Capital Management, LP | 9,413 | $182.1K |
| Citigroup Inc | 467 | $9.04K |
Not filed for Q1 2023 yet (1)
Institutions that held Vera Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Abingworth LLP | 2,960,231 | $57.3M |